Avalyn Announces Multiple Presentations at the Pulmonary Fibrosis Foundation (PFF) Summit 2025
BOSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced multiple presentations at the Pulmonary Fibrosis Foundation (PFF) Summit 2025 being held November 13-15, 2025, in Chicago, Illinois. “We are proud to present four posters […]